ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,088, issued on June 17, was assigned to Revolo Biotherapeutics Ltd. (Great Shelford, Great Britain).
"Method for the treatment of a relapsing-remitting condition" was invented by Andrew Lightfoot (Cambridgeshire, Great Britain), Nicola Cooper (Cambridgeshire, Great Britain), Donata Federici Canova (Cambridgeshire, Great Britain) and Roly Foulkes (Marlow, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method for the acute treatment of a relapsing-remitting condition, the method comprising the step of administering to a subject in need thereof one or more doses of an effective amount of a peptide molecu...